# Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A. – FDA Inspection, Sep 30, 2021

Source: https://www.keypedia.com/records/fda_inspections/istituto-di-ricerche-biomediche-antoine-marxer-rbm-spa/96b1a369-21d3-4c39-bfb3-9799df0f9955
Source feed: FDA_Inspections

> FDA inspection 1169368 of Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A., September 30, 2021. Classification: Voluntary Action Indicated (VAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1169368
- Company Name: Istituto di Ricerche Biomediche Antoine Marxer RBM S.p.A.
- Inspection Date: 2021-09-30
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1028388 - 2017-07-04](https://www.keypedia.com/records/fda_inspections/istituto-di-ricerche-biomediche-antoine-marxer-rbm-spa/39e48fa6-b64c-4898-adaf-cbfd4e099e06)
- FDA Inspection 895868 - 2014-07-04
- FDA Inspection 733880 - 2011-06-24

Company: https://www.keypedia.com/companies/istituto-di-ricerche-biomediche-antoine-marxer-rbm-spa/fb802621-768c-4098-a61f-4add787196a0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c